OR WAIT null SECS
November 17, 2014
Avastin plus chemotherapy for the treatment of ovarian cancer increased progression-free survival by 62% compared with chemotherapy alone.
After being plagued by numerous delays, Lemtrada (alemtuzumab) has finally been approved by FDA for the treatment of multiple sclerosis.
November 15, 2014
Advanced analytical methods are speeding up the targeted evaluation of potential viral contaminants.
October 31, 2014
Amgen is suing Sandoz over Sandoz's biosimilar application for filgrastim.
October 30, 2014
Sigma-Aldrich's custom manufacturing services business unit, SAFC, has launched a new protein quality supplement for biological drug production, including biosimilars.
October 20, 2014
The agency recommends that companies developing drugs to treat Ebola apply for orphan drug designation.
October 02, 2014
Demand for new therapies and vaccines spotlights production challenges.
September 26, 2014
Partnership is awarded for licensing of low-cost vaccine for the treatment of bacterial meningitis.
September 25, 2014
USP expresses its support for a consensus-based global approach to the naming of biologics.
August 02, 2014
Customers are looking to reduce risk, increase performance, and optimize productivity.